Physician profile
Sam Nosrati
NPI 1164795209
$9,175.13
in general payments reported to CMS, 2019-2025
42 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $377 · 2021: $465 · 2022: $665 · 2023: $2,551 · 2024: $2,717 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,543 · Travel and Lodging: $2,406 · Long Term Medical Supply Or Device Loan: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,542.92 |
| Travel and Lodging | $2,405.69 |
| Long Term Medical Supply Or Device Loan | $497.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,085.78 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $1,556.07 | 2023-2025 | Monkey Rings, Portfolio, Precision Mis Bunion |
| Treace Medical Concepts, INC. | $905.38 | 2019-2025 | |
| Stryker Corporation | $753.88 | 2020-2025 | Prophecy, Augment Injectable, Citrefix |
| Smith+Nephew, INC. | $569.03 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Footprint |
| Biotissue Holdings INC. | $556.15 | 2022-2024 | |
| Inari Medical, INC. | $443.33 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Depuy Synthes Sales INC. | $344.66 | 2019-2025 | Na, Hammerlock |
| Horizon Therapeutics Plc | $279.10 | 2019-2023 | Krystexxa |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Abbott Laboratories | $172.90 | 2023 | Eterna, Proclaim |
| Polynovo North America LLC | $138.39 | 2024-2025 | Novosorb Btm |
| Wright Medical Technology, INC. | $112.88 | 2019 | |
| Melinta Therapeutics, LLC | $109.93 | 2019 | |
| Davol INC. | $101.12 | 2022-2025 | Arista |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $86.76 | 2022 | |
| Tactile Systems Technology INC | $67.19 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $58.67 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $55.89 | 2021-2023 | Puraply |
| Abbvie INC. | $52.70 | 2023 | |
| Zimmer Biomet Holdings, INC. | $50.75 | 2019 | |
| Surgenex LLC | $40.65 | 2025 | Surgraft, Ardeograft, Pellograft |
| Aroa Biosurgery Incorporated | $37.01 | 2022 | |
| Medtronic, INC. | $36.67 | 2024 | Intellis Adaptivestim |
| Ani Pharmaceuticals, INC. | $33.17 | 2025 | Purified Cortrophin Gel |
| Molnlycke Health Care US, LLC | $27.18 | 2025 | Exufiber, Exufiber Ag+, Mepilex Border Flex |
| Corcept Therapeutics | $26.91 | 2025 | Korlym |
| Musculoskeletal Transplant Foundation INC. | $26.67 | 2019 | |
| Curonix LLC | $23.83 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $23.50 | 2024 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.47 | 2023 | Jublia |
| Averitas Pharma INC. | $22.15 | 2023 | Qutenza |
| Cardiovascular Systems INC. | $22.15 | 2019 | |
| Djo, LLC | $21.56 | 2024 | Aircast |
| Medline Industries LP | $20.09 | 2020 | |
| Pfizer INC. | $18.45 | 2019 | |
| Advanced Oxygen Therapy INC. | $16.89 | 2025 | Topical Oxygen Chamber For Extremities |
| Reprise Biomedical, INC. | $16.75 | 2024 | Miro3d |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2023 | Seglentis |
| Bioventus LLC | $15.71 | 2019 | |
| Sandoz INC. | $14.11 | 2020 | |
| Lifenet Health | $14.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Nosrati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.